Why the study?
Does a vaccination schedule combining live and inactivated poliovirus vaccines reduce the incidence of poliomyelitis in Gaza compared to TOPV alone?
Does a vaccination schedule combining live and inactivated poliovirus vaccines reduce the incidence of poliomyelitis in Gaza compared to TOPV alone?
Combining live and inactivated poliovirus vaccines successfully controlled poliomyelitis in a developing region where the oral vaccine alone was insufficient.
Associated with sharp incidence drop in Gaza; hypothesis-generating for combined schedules where TOPV alone fails, pending RCTs.
Trivalent oral poliovirus vaccine ( TOPV ) has been used in Gaza since 1967. After an initial decrease of 33% in the incidence of the paralytic disease, no further decrease could be noted. The mean annual incidence until 1977 was 10 per 100,000 inhabitants. Two outbreaks caused by poliovirus type 1 were registered in 1974 and 1976 with an incidence of 18 per 100,000 inhabitants. In these outbreaks, 34% and 50% of the affected children, respectively, had received three to four doses of TOPV . A new vaccination schedule was introduced in 1978, combining live and inactivated poliovirus vaccines. In the years 1978-1980, the incidence decreased to 2.6 per 100,000 inhabitants; and during 1981-1982, only three cases were recorded. These results indicate that a schedule like the one used in Gaza could serve as a model to control poliomyelitis in developing countries where TOPV alone is not successful.
No takes yet. Share an insight, caveat, or question.
Lasch et al. (1984) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: